The reliability of the Scale for the Evaluation and Identification of Seizures, Epilepsy, and Anticonvulsant Side Effects-B (SEIZES B)

Research in Developmental Disabilities

Volumn 26, Issue 6, 2005, Pages 593-599

  Matson, Johnny L ^a   Laud, Rinita B ^a   González, Melissa L ^a   Malone, Carrie J ^a   Swender, Stephen L ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Pinecrest Developmental Center   (United States)

Author keywords

AED; Intellectual disabilities (ID); SEIZES B

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ANTICONVULSANT ACTIVITY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIZZINESS; EPILEPSY; FEMALE; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HAIR DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PSYCHOMETRY; RATING SCALE; RELIABILITY; RESPIRATORY FAILURE; SEDATION; SEIZURE; SIDE EFFECT; SKIN DISEASE; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; OBSERVER VARIATION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEIZURES;

EID: 27844466788     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ridd.2004.11.011     Document Type: Article

References (17)

1. N. Alvarez, F. Besag, and M. Iivanainen Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability Journal of Intellectual Disability Research 42 Suppl. 1 1998 1 15
2. A.J. Cole Evaluation and treatment of epilepsy in multiply handicapped individuals Epilepsy and Behavior 3 2002 S2 S6
3. D.L. Coulter Epilepsy and mental retardation: An overview American Journal on Mental Retardation 98 Suppl. 1-11 1993 1 10
4. W.I. Fraser M. Iivanainen N. Alvarez Drug treatment of epilepsy in people with intellectual disability Journal of Intellectual Disability Research 42 Suppl. 1 1998
5. J. Kalachnik Assessment sheet for Monitoring of Side-Effects System (MOSES) A. Poling K. Gadow J. Cleary Drug therapy for behavior disorders: An introduction 1986 Pergamon Press New York 153 155
6. A.M. Kanner Psychiatric comorbidy in patients with developmental disorders and epilepsy: A practical approach to its diagnosis and treatment Epilepsy and Behavior 3 2002 S7 S13
7. J.L. Matson, E.A. Mayville, and J.W. Bamburg An analysis of side-effect profiles of anti-seizure medications in persons with intellectual disability using the Matson Evaluation of Drug Side Effects (MEDS) Journal of Intellectual and Developmental Disability 26 2001 283 295
8. J.L. Matson, E.A. Mayville, J. Bielecki, W.H. Barnes, J.W. Bamburg, and C.S. Baglio Reliability of the Matson Evaluation of Drug Side Effects (MEDS) Research in Developmental Disabilities 19 1998 501 506
9. R.H. Mattson The role of the old and the new antiepileptic drugs in special populations: Mental and multiple handicaps Epilepsia 37 1996 195
10. Mayville, E. A., & Matson, J. L. (2000). The Matson and Mayville (M&M) seizure scale: An assessment of psychological and environmental variables contributing to seizure activity in persons with mental retardation. Unpublished dissertation.
11. M.J. Mycek, R.A. Harvey, and P.C. Champe In Lippincott's illustrated reviews: Pharmacology 2nd ed. 1997 Raven Publishers Philadelphia
12. National Institute of Mental Health Abnormal Involuntary Movement Scale (AIMS) 1985 Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration Washington
13. J.M. Pellock Treatment considerations: Traditional antiepileptic drugs Epilepsy and Behavior 3 2002 S18 S23
14. P.A. Rutecki, and B.E. Gidal Antiepileptic drug treatment in the developmentally disabled: Treatment considerations with the newer antiepileptic drugs Epilepsy and Behavior 3 2002 S24 S31
15. R. Sprague, J. Kalachnik, S. Bruening, V. Davis, R. Ullmann, and S. Cullari The Dyskinesia Identification System - Coldwater (DISCo): A tardive dyskinesia rating scale for the developmentally disabled Psychopharmacology Bulletin 20 1984 328 338
16. E.P.G. Vining, R.O. Carpenter, and M.G. Aman Antiepileptics (anticonvulsants) J.S. Werry M.G. Aman Practitioner's guide to psychoactive drugs for children and adolescents 2nd ed. 1999 Plenum Publishing Corporation New York 355 385
17. A.A. Wilfong Treatment considerations: Role of vagus nerve stimulator Epilepsy and Behavior 3 2002 S41 S44